← Back to Search

Local Anesthetic

Lidocaine for Pain Control During Endovenous Laser Treatments

N/A
Waitlist Available
Research Sponsored by Midwest Vein Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Large Saphenous Vein treatment
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 24 hours
Awards & highlights

Study Summary

This trial is testing whether a lower concentration of lidocaine in tumescent anesthesia is just as effective as the standard dose for pain management in endovenous laser treatments, in order to reduce the risk of lidocaine toxicity.

Who is the study for?
This trial is for individuals aged 16-85 in good health who require endovenous laser treatment (EVLT) for varicose veins and can understand the consent process. It's not suitable for those with bleeding disorders, lidocaine sensitivity, liver issues, heart failure or if pregnant.Check my eligibility
What is being tested?
The study tests whether a lower concentration of lidocaine in tumescent anesthesia is as effective as the standard dose for pain control during and after EVLT. Participants will be randomly assigned to receive either the standard or reduced dose.See study design
What are the potential side effects?
Potential side effects include symptoms related to lidocaine toxicity such as dizziness, numbness, tingling sensations, confusion or seizures if serum levels become too high.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am receiving treatment for my large saphenous vein.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~24 hours
This trial's timeline: 3 weeks for screening, Varies for treatment, and 24 hours for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Pain

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: 1/4 dose lidocaineExperimental Treatment1 Intervention
12.5mL 1% lidocaine in 487.5mL normal saline
Group II: Standard LidocaineActive Control1 Intervention
50mL 1% lidocaine in 450mL normal saline
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Lidocaine
FDA approved

Find a Location

Who is running the clinical trial?

Midwest Vein CenterLead Sponsor

Media Library

Lidocaine (Local Anesthetic) Clinical Trial Eligibility Overview. Trial Name: NCT02192411 — N/A
Pain Research Study Groups: Standard Lidocaine, 1/4 dose lidocaine
Pain Clinical Trial 2023: Lidocaine Highlights & Side Effects. Trial Name: NCT02192411 — N/A
Lidocaine (Local Anesthetic) 2023 Treatment Timeline for Medical Study. Trial Name: NCT02192411 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What research has been conducted to evaluate the efficacy of Lidocaine?

"Presently, 118 clinical trials on lidocaine are in operation with 31 of those studies occurring during the third phase. Although a majority are situated in Calgary, Alberta, 1094 sites worldwide have initiated research into this remedy."

Answered by AI

How many individuals is the research group recruiting for this trial?

"Unfortunately, this trial has closed its participant recruitment period. It was originally posted on July 1st 2014 and underwent a final update 2 weeks later. If you are seeking alternative trials that involve lidocaine, there are currently 119 studies actively recruiting patients with the drug in question."

Answered by AI

Are researchers still taking on participants for this project?

"As evidenced on clinicaltrials.gov, this experiment is not currently acquiring participants; the initial post date was July 1st 2014 and it has been recently revised on July 15th 2014. However, there are still 119 other trials actively accepting applicants at this moment in time."

Answered by AI

In what medical contexts is Lidocaine typically employed?

"The anesthetic lidocaine is frequently utilized to treat cervical syndrome, but can also be used in cases of minor burns, organ transplantation operations and even osteoporosis."

Answered by AI

What eligibility criteria must be met for participation in this medical experiment?

"This clinical trial requires 70 individuals aged between 16 and 85 currently experiencing lidocaine. To be eligible, they must also satisfy certain conditions such as Large Saphenous Vein treatment eligibility, healthiness, comprehension of the informed consent document, and approval from a physician for EVLT."

Answered by AI

Are applicants aged 30 and older eligible to partake in this experiment?

"This experiment is seeking participants that are aged 16-85."

Answered by AI
~7 spots leftby Apr 2025